You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

eribulin

Showing 1 - 25 of 64
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Solid Tumors Trial in Houston (Eribulin, Irinotecan, Temozolomide)

Recruiting
  • Refractory Solid Tumors
  • Eribulin
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 22, 2023

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (MEN1611, Eribulin)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • (no location specified)
Apr 12, 2023

Breast Cancer Trial in Tampa (Eribulin, Carboplatin)

Completed
  • Breast Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Oct 28, 2022

Leiomyosarcoma, Liposarcoma, Soft Tissue Sarcoma Adult Trial in Taipei (Eribulin, Lenvatinib)

Active, not recruiting
  • Leiomyosarcoma
  • +3 more
  • Taipei, Taiwan
  • +1 more
Dec 27, 2022

Inflammatory Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Trial in Boston (Eribulin, Adriamycin,

Active, not recruiting
Has Results
  • Inflammatory Breast Cancer
  • Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
  • Eribulin
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 28, 2022

Breast Cancer Trial (Tucatinib, Eribulin, Trastuzumab)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jul 12, 2022

TNBC - Triple-Negative Breast Cancer Trial in Beijing (Eribulin, anti-PD-1 antibody)

Recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Eribulin
  • anti-PD-1 antibody
  • Beijing, Beijing, China
    The Fifth Medical Center of PLA General Hospital
May 29, 2022

Breast Cancer, Metastatic Triple-Negative Breast Cancer Trial in United States (Eribulin, SDX-7320, Placebo)

Recruiting
  • Breast Cancer
  • Metastatic Triple-Negative Breast Cancer
  • Eribulin
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Oct 4, 2022

Angiosarcoma, Epithelioid Hemangioendothelioma Trial in Boston (Eribulin)

Recruiting
  • Angiosarcoma
  • Epithelioid Hemangioendothelioma
  • Eribulin
  • Boston, Massachusetts
  • +1 more
Feb 14, 2022

Relapsed Solid Tumors, Refractory Solid Tumors Trial in Aurora, Lexington, Dallas (Eribulin, Irinotecan, Cefixime)

Completed
  • Relapsed Solid Tumors
  • Refractory Solid Tumors
  • Eribulin
  • +2 more
  • Aurora, Colorado
  • +2 more
Jan 31, 2022

Solitary Fibrous Tumor Trial in Italy (Eribulin)

Recruiting
  • Solitary Fibrous Tumor
  • Eribulin
  • Palermo, PA, Italy
  • +3 more
Oct 29, 2021

Breast Cancer Trial in Spain (Eribulin)

Terminated
  • Breast Cancer
  • Eribulin
  • Jaen, Jaén, Spain
  • +8 more
Aug 26, 2021

Recurrent Breast Inflammatory Carcinoma, Stage IV Breast Inflammatory Carcinoma Trial in Houston (Atezolizumab, Cobimetinib,

Recruiting
  • Recurrent Breast Inflammatory Carcinoma
  • Stage IV Breast Inflammatory Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2021

Metastatic Breast Cancer Trial (SKB264, Eribulin, Capecitabine)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Oct 7, 2023

Breast Cancer Trial in Guangzhou, Shanghai (Camrelizumab, Apatinib, Eribulin)

Active, not recruiting
  • Breast Cancer
  • Guangzhou, Guangdong, China
  • +2 more
Jul 24, 2021

HER2-negative Breast Cancer, Advanced Breast Cancer Trial in Guangzhou (Organoid-guided treatment, Taxane, Capecitabine)

Not yet recruiting
  • HER2-negative Breast Cancer
  • Advanced Breast Cancer
  • Organoid-guided treatment
  • +5 more
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Oct 22, 2023

Breast Cancer Trial in Houston (Paclitaxel, Eribulin, 5-Fluorouracil)

Completed
Has Results
  • Breast Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 26, 2021

Triple Negative Breast Cancer Trial in Shanghai (Eribulin, Tislelizumab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
May 29, 2021

Advanced Breast Cancer Trial (POL6326, Eribulin, Nab paclitaxel)

Not yet recruiting
  • Advanced Breast Cancer
  • (no location specified)
Apr 6, 2021

Resolution of Eribulin-Induced Peripheral Neuropathy

Completed
  • Locally Advanced or Metastatic Breast Cancer
  • Eribulin
  • Amberg, Germany
  • +65 more
Jul 12, 2022

1st-line or 2nd-line Chemotherapy for HER2-negative

Completed
  • Breast Cancer
  • Eribulin
  • Kobe-city, Hyogo-prefecture, Japan
  • +1 more
Jun 10, 2021

Cancer, Solid Tumor Trial in San Antonio (Eribulin, Lenvatinib)

Unknown status
  • Cancer
  • Solid Tumor
  • San Antonio, Texas
    Cancer Therapy and Research Center University of Texas Health Sc
Mar 1, 2021

Breast Cancer, HER2-negative Breast Cancer Trial in Canada, United States (Paclitaxel, Eribulin, Doxorubicin)

Completed
Has Results
  • Breast Cancer
  • HER2-negative Breast Cancer
  • Denver, Colorado
  • +19 more
Oct 4, 2021

Metastatic Breast Cancer, Chemo-induced Alopecia Trial in Boston (Paxman Scalp Cooling System, Eribulin, Sacituzumab govitecan)

Recruiting
  • Metastatic Breast Cancer
  • Chemotherapy-induced Alopecia
  • Paxman Scalp Cooling System
  • +3 more
  • Boston, Massachusetts
  • +1 more
Jan 18, 2022

Standard Anti-microtubule Drugs as Assessed by Early Tumor

Recruiting
  • Breast Cancer
  • Breast Neoplasms
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Dec 10, 2021